Lansoprazolo Aurobindo

Lansoprazole, the active ingredient in Lansoprazolo Aurobindo, is a proton pump inhibitor presented as a unknown/unknown for oral use. It reduces gastric acid secretion in adults with acid‑related gastrointestinal conditions.

GNH USA supplies Lansoprazolo Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazolo Aurobindo is a proton pump inhibitor used to manage acid‑related disorders of the gastrointestinal tract. - Gastro‑esophageal reflux disease (GERD): provides symptomatic relief by decreasing reflux of acidic gastric contents. - Peptic ulcer disease: promotes ulcer healing by maintaining a low‑acid environment. - Helicobacter pylori eradication (in combination therapy): enhances the effectiveness of antibiotic regimens. - Prevention of NSAID‑induced gastric ulcers: reduces the risk of ulcer formation in patients requiring non‑steroidal anti‑inflammatory drugs.

Lansoprazolo Aurobindo may be associated with a range of adverse reactions.

Common Side Effects: - Headache: mild to moderate pain often transient. - Diarrhea: loose stools that may resolve with continued therapy. - Nausea: feeling of unease or upset stomach. - Abdominal pain: discomfort in the upper abdomen. - Flatulence: increased gas production. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): swelling, difficulty breathing, rash. - Clostridioides difficile infection: persistent watery diarrhea, abdominal cramping. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Bone fractures (with long‑term use): increased risk of hip, wrist, or spine fractures. - Liver enzyme elevation: signs of hepatitis such as jaundice. - Acute interstitial nephritis: kidney inflammation presenting with fever and rash.

Before initiating therapy, consider the following precautions. - Assess renal function: dose adjustment may be needed in severe impairment. - Evaluate hepatic status: monitor for liver enzyme changes. - Review concomitant medications: potential for drug‑drug interactions. - Use with caution in the elderly: higher risk of fractures and infections. - Avoid prolonged use without medical supervision: risk of nutrient deficiencies. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Lansoprazolo Aurobindo can affect the pharmacokinetics of several drugs.

Major Interactions (Avoid): - Ketoconazole and itraconazole: reduced antifungal absorption. - Atazanavir and nelfinavir: decreased antiviral efficacy. - Warfarin: potential increase in anticoagulant effect.

Moderate Interactions (Monitor Closely): - Digoxin: possible increase in serum levels. - Methotrexate (high dose): enhanced toxicity risk. - Clopidogrel: reduced antiplatelet activity. - Iron supplements: decreased iron absorption. - Vitamin B12: long‑term therapy may impair absorption.